DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Carr B, Dmowski WP, OʼBrien C. et al.
Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density.
Reprod Sci 2014;
21: 1341-1351
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.